Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Shorts Up 6.79% - Shares Trading Down

Marco Green
September 26, 2017

They now have a United States dollars 13 price target on the stock. It has outperformed by 7.74% the S&P500. Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has risen 24.44% since September 21, 2016 and is uptrending. Price T Rowe Assoc Inc Md holds 50,607 shares or 0% of its portfolio. Lastly, Canaccord Genuity fixed a $13.00 target price on the stock of Synergy Pharmaceuticals and issued the company a buy recommendation in a study note on early Mon, Jul 31st. around three Brokerage firms have recommended the share with a sell recommendation, 1 have issued a hold recommendation and nine have published a buy recommendation to the firms shares.

Synergy Pharmaceuticals Inc. (SGYP)'s bearish picture have been built after taking the consideration of last five trading activity. Bancshares Of Montreal Can has invested 0% in Synergy Pharmaceuticals Inc (NASDAQ:SGYP). The consensus rating is 2, indicating analysts in general look favorably on the company's future prospects. Ruggie Grp reported 25 shares stake.

Investors sentiment increased to 1.09 in 2017 Q2. Tourbillon Capital Prns Ltd Partnership reported 0.36% in Synergy Pharmaceuticals Inc (NASDAQ:SGYP). The stock volatility for week was 4.75% while for month was 5.13%. Dundee Securities upgraded the stock to "Buy" rating in Tuesday, July 19 report. With short interest at 67,570,644 and short average daily volume at 2,888,418, the short-interest ratio is 23.0 and the percentage of shorted shares was 0.30% on August 31. 56 funds opened positions while 186 raised stakes.

Is Synergy Pharmaceuticals Inc. The firm has "Buy" rating given on Thursday, October 29 by TH Capital. It is negative, as 31 investors sold Synergy Pharmaceuticals Inc shares while 22 reduced holdings. Hirtle Callaghan Ltd Limited Liability Company invested 0% in Walt Disney Co (NYSE:DIS).

All these opinions have come together to present the composite price target for the stock. Short-term as well long term investors always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was recorded 1.90 as current ratio and on the opponent side the debt to equity ratio was - and long-term debt to equity ratio also remained -.

The collective rating of 1.8 for Teladoc, Inc. The market capitalization of the company is at $593.87 Million. Therefore 22% are positive. Axiom Interest Limited Liability Corp De owns 926,935 shares or 0.1% of their U.S. portfolio. The Return on Assets for Synergy Pharmaceuticals Inc.

Hedge funds and other institutional investors have recently bought and sold shares of the business. During the last 52 weeks, the price has been as high as $7.15 and as low as $2.57. Williams Jones Assoc Lc stated it has 0% in Synergy Pharmaceuticals Inc (NASDAQ:SGYP).

Nutanix, Inc. (NASDAQ:NTNX) shares ended at $23.46 with 4.74 mln shares exchanging hands.

Beta is also an important valuation ratio for analyzing the stock of the company, SGYP has its industry and Sector's beta remains at 0.85 and 0.77 respectively. These players show their main role in buy or sell enormous chunks. The count of Hold ratings in that period was 0.

Chilton Capital Management Llc, which manages about $1.18B and $905.82M US Long portfolio, decreased its stake in Crown Castle Intl Corp New (NYSE:CCI) by 46,674 shares to 164,561 shares, valued at $16.49 million in 2017Q2, according to the filing. Edgestream Prtn Limited Partnership holds 5,236 shares or 0.24% of its portfolio. The firm has "Buy" rating given on Friday, September 8 by Cantor Fitzgerald. Thompson Davis And Inc holds 13 shares. Edgepoint Group Inc Inc Inc has invested 0% in Fiserv Inc (NASDAQ:FISV). Essex Inv Mgmt Lc invested in 0.44% or 52,154 shares. Nikko Asset Management Americas invested in 102,600 shares. Out of 8 Wall Street analysts rating Buffalo Wild Wings, 2 give it "Buy", 2 "Sell" rating, while 4 recommend "Hold". The stock of Starbucks Corporation (NASDAQ:SBUX) earned "Neutral" rating by Wedbush on Wednesday, June 14. State Common Retirement Fund reported 0% of its portfolio in Synergy Pharmaceuticals Inc (NASDAQ:SGYP). Sg Americas Secs Lc reported 22,002 shares. The company was maintained on Tuesday, August 22 by Jefferies.

News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synergy Pharmaceuticals, Inc. with's FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article